Back to search
FDAFDA · Food and drugs·Recall number D-0147-2017

Amoxicillin for Oral suspension, USP 400 mg/5 mL, 100 mL (when reconstituted), Rx only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 183400, Amman 11118 - Jordan, NDC 0143-9887-01

Published November 30, 2016 · Recall initiated: November 4, 2016

Summary

FDA records drug Class III recall D-0147-2017, published November 30, 2016 and initiated November 4, 2016. Recalling firm: West-Ward Pharmaceuticals Corp.; Status: Terminated; Reported quantity: 32,102 bottles; Lot: Lot #: AS1466A, Exp. Jan 2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Error on Declared Strength: Some bottles miss a color coded panel where the strength of the product is typically displayed.

What to do

Voluntary: Firm initiated · Letter

Get an email if AMOXICILLIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
AMOXICILLIN
Manufacturer
West-Ward Pharmaceuticals Corp.
Distributor
Nationwide
UPC
0301439887508
Lot
Lot #: AS1466A, Exp. Jan 2019
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Amoxicillin for Oral suspension, USP 400 mg/5 mL, 100 mL (when reconstituted), Rx only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 183400, Amman 11118 - Jordan, NDC 0143-9887-01 recalled?

Yes. FDA published recall D-0147-2017 on November 30, 2016. Reported hazard: Labeling: Label Error on Declared Strength: Some bottles miss a color coded panel where the strength of the product is typically displayed.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: AMOXICILLIN. UPC: 0301439887508.